Related Experiment Videos

[Increased HDL-cholesterol level improves the prognosis in patients with coronary vasospasm]

K Miwa1, Y Miyagi, M Fujita

  • 1Second Department of Internal Medicine, Toyama Medical and Pharmaceutical University.

Journal of Cardiology
|September 1, 1994
PubMed

Insights

Patients with vasospastic coronary artery disease experiencing cardiovascular events had lower high-density lipoprotein cholesterol (HDL-C) levels and were more likely to be smokers. Smoking cessation may be crucial for managing vasospastic angina and preventing adverse cardiovascular events.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Preventive Cardiology

Context:

  • Vasospastic coronary artery disease (CAD) poses a risk for cardiovascular events.
  • Diagnostic coronary arteriography is used to confirm coronary artery spasm.
  • Long-term follow-up is essential for assessing outcomes in patients with vasospastic CAD.

Purpose:

  • To analyze cardiovascular events in patients with vasospastic CAD.
  • To identify risk factors associated with cardiovascular events in this patient subset.
  • To investigate the role of lipid profiles, particularly high-density lipoprotein cholesterol (HDL-C), and smoking status in cardiovascular outcomes.

Summary:

  • A study of 49 patients with vasospastic CAD found that 7 patients experienced cardiovascular accidents (myocardial infarction, unstable angina, stroke) during a 30-month follow-up.
  • These events were significantly more common in current smokers (71%) compared to non-smokers (12%).
  • While baseline lipid levels, including HDL-C, did not differ, HDL-C levels increased in event-free patients but decreased in those with events. Final HDL-C was significantly lower in the event group.

Impact:

  • Current smoking is a significant risk factor for cardiovascular events in vasospastic CAD.
  • Declining HDL-C levels during follow-up are associated with adverse cardiovascular events.
  • These findings highlight the importance of smoking cessation and monitoring HDL-C levels for managing patients with vasospastic angina.

Related Concept Videos